TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3966617

Group type: EXPERIMENTAL
Intervention: Home health care team approach (physician, nurse practitioner, social worker)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home health care team approach
Number of subjects: 0
Study: 30206908

Group type: EXPERIMENTAL
Intervention: Comprehensive video tutorials (group B, n=12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard instructional videos (group A, n=12)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Group B
Number of subjects: 24
Study: 28940335

Group type: EXPERIMENTAL
Intervention: Patient navigator intervention
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 61
Study: 26205801

Group type: EXPERIMENTAL
Intervention: Intravenous Desferrioxamine, 40 mg/kg/day, 6 days per week for 6 months
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Subcutaneous Desferrioxamine, 40 mg/kg/day, 6 days per week 8-12 hours per day for 6 months
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oral Deferiprone, 75 mg/kg/day in three divided doses daily for 6 months
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oral Deferasirox, 30 mg/kg/day in single dose on empty stomach daily for 6 months
Number of subjects: 120
Study: 22913332

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) (≥180 seconds, n = 193)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Early cord clamping (ECC) (≤10 seconds, n = 189)
Number of subjects: 382
Study: 20016927

Group type: EXPERIMENTAL
Intervention: Sorafenib (400 mg twice daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 19741188

Group type: EXPERIMENTAL
Intervention: high-carbohydrate/high-fiber diet (52% total energy, 28 g/1,000 kcal fiber, low glycemic index 58%)
Number of subjects: 18

Group type: COMPARATOR
Intervention: low-carbohydrate/high-monounsaturated fat diet (45% carbohydrate, 23% monounsaturated fat)
Number of subjects: 18
Study: 17121134

Group type: EXPERIMENTAL
Intervention: Continuous MgSO4 infusion (12 grams in 500 ml normal saline daily for 12 days)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no MgSO4 infusion)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: MgSO4 infusion
Number of subjects: 76
Study: 15562907

Group type: COMPARATOR
Intervention: Enamel matrix derivative (EMD) alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD) + demineralized freeze-dried bone allograft (DFDBA)
Number of subjects: 40
Study: 11329798

Group type: EXPERIMENTAL
Intervention: Verteporfin (Visudyne) used in conjunction with laser activation (photodynamic therapy) for AMD treatment
Number of subjects: 0
Study: 9158305

Group type: EXPERIMENTAL
Intervention: PGE2 gel (Prepidil) 0.5 mg in 2.5 ml of triacetin gel
Number of subjects: 185

Group type: COMPARATOR
Intervention: Hygroscopic mechanical dilators (Dilapan) - up to 4 dilators placed in the endocervical canal
Number of subjects: 185
Study: 7962672

Group type: EXPERIMENTAL
Intervention: 60 mg nimodipine orally
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2.0 mg/kg tirilazad mesylate as a 10‐minute intravenous infusion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of nimodipine and tirilazad mesylate
Number of subjects: 12
Study: 3609067

Group type: EXPERIMENTAL
Intervention: Oral dose of 10 mg dihydroergosine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenous dose of 0.75 mg dihydroergosine
Number of subjects: 8
Study: 30615075

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 29415825

Group type: EXPERIMENTAL
Intervention: Green tea extract (1 g daily)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Metformin (1 g daily)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (1 g cellulose daily)
Number of subjects: 120
Study: 26171380

Group type: EXPERIMENTAL
Intervention: Morning aerobic exercises and medicine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Afternoon aerobic exercises and medicine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Medicine only
Number of subjects: 45
Study: 23649920

Group type: EXPERIMENTAL
Intervention: PEEP 5 cmH(2)O (PEEP group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Zero positive end‐expiratory pressure (ZEEP group)
Number of subjects: 40
Study: 21812891

Group type: EXPERIMENTAL
Intervention: PF-04603629 (70 mg)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 19499866

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control (Fentanyl and Propofol)
Number of subjects: 300
Study: 16623961

Group type: EXPERIMENTAL
Intervention: 9-repeat allele of the dopamine transporter (DAT1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 9-repeat allele of the dopamine transporter (DAT1) in depressed patients aged >= 35 years
Number of subjects: 0
Study: 15338802

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 519

Group type: COMPARATOR
Intervention: Ipratropium
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Treatment arm
Number of subjects: 519
Study: 12052991

Group type: EXPERIMENTAL
Intervention: Intra-arterial recombinant prourokinase plus intravenous heparin
Number of subjects: 180

Group type: COMPARATOR
Intervention: Intravenous heparin only
Number of subjects: 180
Study: 9883209

Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory (BDI)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Profile of Mood States (POMS)
Number of subjects: 350
Study: 8520194

Group type: EXPERIMENTAL
Intervention: IVF with sperm treated with pentoxifylline (PF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subzonal sperm insemination (SUZI) with sperm treated with pentoxifylline (PF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Micromanipulation by partial zona dissection (PZD) with sperm treated with pentoxifylline (PF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IVF with sperm stimulants (PF alone or PF + 2DA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SUZI or PZD
Number of subjects: 0
Study: 2266066

Group type: EXPERIMENTAL
Intervention: Aminophylline injection in patients with mild spontaneous attacks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stable bronchial asthmatic patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atopic patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with spontaneous attacks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bronchial asthmatic patients having attacks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mild and moderate asthmatic subjects
Number of subjects: 0
Study: 192560

Group type: EXPERIMENTAL
Intervention: 10 mg trimeprazine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 20 mg trimeprazine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Withdrawal after 10 mg and 20 mg
Number of subjects: 8
Study: 31601606

Group type: EXPERIMENTAL
Intervention: ABAaNA EIP (10-modular, peer-facilitated, participatory, community-based programme over 6 months)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 126
Study: 29282267

Group type: EXPERIMENTAL
Intervention: Diet and exercise programme for 18 weeks, followed by cognitive behavioural therapy, knee brace, or muscle strengthening for 12 weeks if remission is not achieved
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Diet and exercise programme for 18 weeks
Number of subjects: 170

Group type: COMPARATOR
Intervention: Educational material related to OA management
Number of subjects: 170
Study: 25403717

Group type: EXPERIMENTAL
Intervention: HPV self-sample kit
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Further invitation for cytology screening
Number of subjects: 6000
Study: 25782319

Group type: EXPERIMENTAL
Intervention: Combined therapy with amlodipine and ramipril
Number of subjects: 130
Study: 23059151

Group type: EXPERIMENTAL
Intervention: TREA interventions for unmet needs
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 125
Study: 19888560

Group type: EXPERIMENTAL
Intervention: Olanzapine (7.5 mg)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Olanzapine (7.5 mg) plus mifepristone (600 mg)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Mifepristone (600 mg)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Olanzapine plus mifepristone (600 mg)
Number of subjects: 57
Study: 17568325

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (150 mg/kg loading dose; 15 mg/kg/hr continuous infusion)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 15064264

Group type: EXPERIMENTAL
Intervention: Radial nerve blocked before ulnar nerve (Group I)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ulnar nerve blocked before radial nerve (Group II)
Number of subjects: 60
Study: 11837735

Group type: EXPERIMENTAL
Intervention: 200 mg intravenous erythromycin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9830087

Group type: EXPERIMENTAL
Intervention: Negative-pressure, half-facepiece respirators
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different brands of respirators
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ambient exposure levels
Number of subjects: 0
Study: 8085933

Group type: EXPERIMENTAL
Intervention: Daily home exercise program aimed at stretching the hamstrings for 4 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Untreated group (control)
Number of subjects: 14
Study: 29666636

Group type: EXPERIMENTAL
Intervention: Dual-mode stimulation (rTMS + tDCS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: rTMS-only
Number of subjects: 24
Study: 27561823

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Endovenous Laser Ablation (EVLA)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided foam sclerotherapy (UGFS)
Number of subjects: 214
Study: 24889207

Group type: EXPERIMENTAL
Intervention: Sleep restriction (6.5 hr in bed per night for five nights)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Healthy sleep duration (10 hr in bed per night for five nights)
Number of subjects: 50
Study: 23002126

Group type: EXPERIMENTAL
Intervention: Docetaxel (100 mg/m² day 1 q3W)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Vinorelbine (25 mg/m² day 1 q2W)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Crossover to Vinorelbine
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Crossover to Docetaxel
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 35

Group type: COMPARATOR
Intervention: Vinorelbine
Number of subjects: 35
Study: 20682842

Group type: EXPERIMENTAL
Intervention: Flutamide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bicalutamide
Number of subjects: 24
Study: 18171294

Group type: EXPERIMENTAL
Intervention: Combined ART and IL-2 therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: ART alone
Number of subjects: 0
Study: 16983001

Group type: EXPERIMENTAL
Intervention: 0.1% betamethasone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 0.005% calcipotriol
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1% pimecrolimus
Number of subjects: 80

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 80
Study: 12679754

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clopidogrel + Aspirin
Number of subjects: 0
Study: 10764713

Group type: EXPERIMENTAL
Intervention: Intraduodenal fat perfusion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Long chain fatty acids
Number of subjects: 12

Group type: COMPARATOR
Intervention: Medium chain fatty acids
Number of subjects: 12

Group type: COMPARATOR
Intervention: Loxiglumide (CCK-A receptor antagonist) with long chain fatty acids
Number of subjects: 12
Study: 8612393

Group type: EXPERIMENTAL
Intervention: 0.45 mg/kg methylnaltrexone plus 0.05 mg/kg morphine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg morphine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo plus 0.05 mg/kg morphine
Number of subjects: 12
Study: 1483498

Group type: EXPERIMENTAL
Intervention: tetracycline coadministration with mefloquine
Number of subjects: 20

Group type: COMPARATOR
Intervention: mefloquine alone
Number of subjects: 20
Study: 3881608

Group type: EXPERIMENTAL
Intervention: Weight-loss group (mean loss of 4.5 kg [10 lb])
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Sodium-restriction group (mean reduction of 40 mEq/day)
Number of subjects: 496

Group type: COMPARATOR
Intervention: Control group (discontinued medication without dietary intervention)
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Nonoverweight mild hypertensives with sodium restriction
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Overweight mild hypertensives with weight reduction
Number of subjects: 496
Study: 29229466

Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Intravenous electrocoagulation (EC)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both EC and RFA
Number of subjects: 57
Study: 27394382

Group type: EXPERIMENTAL
Intervention: High vegetable and fiber, low-fat diet with daily physical activity goals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 0
Study: 25898404

Group type: EXPERIMENTAL
Intervention: Walking in a forested area
Number of subjects: 0

Group type: COMPARATOR
Intervention: Urban environment (control)
Number of subjects: 0
Study: 23623622

Group type: EXPERIMENTAL
Intervention: Parent aide plus case management services
Number of subjects: 138

Group type: COMPARATOR
Intervention: Case management services only
Number of subjects: 138
Study: 20671550

Group type: EXPERIMENTAL
Intervention: Iodixanol 320
Number of subjects: 60

Group type: COMPARATOR
Intervention: Iopamidol 370
Number of subjects: 60
Study: 28679467

Group type: EXPERIMENTAL
Intervention: GSK2339345
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 16722866

Group type: EXPERIMENTAL
Intervention: Topical antifungal nail lacquer (ciclopirox 8%)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Self-inspection instructions alone (NAFL)
Number of subjects: 70
Study: 12848775

Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg x m(‐2) with zosuquidar 3HCl
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Paclitaxel 225 mg x m(‐2) with zosuquidar 3HCl
Number of subjects: 43

Group type: COMPARATOR
Intervention: Paclitaxel 175 mg x m(‐2) alone
Number of subjects: 43
Study: 10535716

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) administered at home (0.1 mL per kg body weight subcutaneously twice daily)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Standard heparin administered in hospital
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Subcutaneous calcium heparin (SCHep) administered at home (0.5 mL bid)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Standard heparin
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Subcutaneous calcium heparin (SCHep)
Number of subjects: 294
Study: 8559429

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IgIV) treatment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Plasma exchange (PE) treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hospital control group (subarachnoid hemorrhage)
Number of subjects: 100
Study: 1988416

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 6840181

Group type: EXPERIMENTAL
Intervention: Intravenous melphalan (10 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral melphalan (10 mg)
Number of subjects: 6
Study: 29652273

Group type: EXPERIMENTAL
Intervention: Milrinone infusion 0.5 μg/kg/min without a loading dose followed by 0.5‐0.75 μg/kg/min
Number of subjects: 116

Group type: COMPARATOR
Intervention: Milrinone infusion with loading dose 50 μg/kg over 10 min followed by 0.5‐0.75 μg/kg/min
Number of subjects: 116
Study: 27338218

Group type: EXPERIMENTAL
Intervention: Higher-ED milk (3.25% fat)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 150% portion of milk (275 g)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Higher-ED milk (3.25% fat) with increased portion size
Number of subjects: 125
Study: 24844029

Group type: EXPERIMENTAL
Intervention: Modified Perforated Membrane (MPM)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Occlusive Membrane (OM)
Number of subjects: 15
Study: 22045830

Group type: EXPERIMENTAL
Intervention: Ibutilide 1 mg intravenously
Number of subjects: 15
Study: 20045196

Group type: EXPERIMENTAL
Intervention: Iloperidone
Number of subjects: 0
Study: 18951420

Group type: EXPERIMENTAL
Intervention: Er:YAG laser with 250 mJ, 62.5 J/cm2, combined with 2 Hz
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Er:YAG laser with 250 mJ, 62.5 J/cm2, combined with 3 Hz
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Er:YAG laser with 250 mJ, 62.5 J/cm2, combined with 4 Hz
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Er:YAG laser with 350 mJ, 87.5 J/cm2, combined with 2 Hz
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Er:YAG laser with 350 mJ, 87.5 J/cm2, combined with 3 Hz
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Er:YAG laser with 350 mJ, 87.5 J/cm2, combined with 4 Hz
Number of subjects: 91

Group type: COMPARATOR
Intervention: High‐speed handpiece (control)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 91
Study: 16926775

Group type: EXPERIMENTAL
Intervention: saquinavir SGC/ritonavir (1600 mg/100 mg)
Number of subjects: 171

Group type: COMPARATOR
Intervention: efavirenz (600 mg)
Number of subjects: 171
Study: 14700451

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 10769437

Group type: EXPERIMENTAL
Intervention: Alfacalcidol (0.5‐1.0 microgram, mean = 0.54 +/‐ 0.03 microgram)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (500 mg calcium daily)
Number of subjects: 41
Study: 9345173

Group type: COMPARATOR
Intervention: Control group (after delivery supplementation)
Number of subjects: 2047
Study: 8315266

Group type: EXPERIMENTAL
Intervention: Nocturnal oral glucose supplementation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Water (placebo)
Number of subjects: 16
Study: 2961314

Group type: EXPERIMENTAL
Intervention: Intra-arterial (I.A.) 5-fluorodeoxyuridine (FUDR)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Intravenous (I.V.) 5-fluorodeoxyuridine (FUDR)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Intra-arterial (I.A.) 5-fluorodeoxyuridine (FUDR) in patients with negative hepatic lymph nodes
Number of subjects: 64
Study: 29272753

Group type: EXPERIMENTAL
Intervention: Four or more Elixhauser Comorbidity Index (ECI) conditions
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Any one of a subset of ECI conditions
Number of subjects: 777

Group type: COMPARATOR
Intervention: Aboriginal cases with four or more ECI conditions
Number of subjects: 777

Group type: COMPARATOR
Intervention: Aboriginal cases with subset of ECI conditions
Number of subjects: 777
Study: 26427784

Group type: EXPERIMENTAL
Intervention: Sinus infiltration technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lateral sinus lift
Number of subjects: 20
Study: 24586492

Group type: EXPERIMENTAL
Intervention: Memory suppression during recall tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memory recall tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elaborative recall of paired-associates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Task goals requiring recall
Number of subjects: 0
Study: 22693269

Group type: EXPERIMENTAL
Intervention: Nitrogen dioxide (NO2) exposure (400 ppb for 1 hour)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Air (control group)
Number of subjects: 0
Study: 20167461

Group type: EXPERIMENTAL
Intervention: Hop extract (100 mug 8‐prenylnaringenin per day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 17307809

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (clamped at 3 minutes after delivery)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Early cord clamping (clamped within 30 seconds)
Number of subjects: 37
Study: 15790430

Group type: EXPERIMENTAL
Intervention: Laparoscopy (LPS)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Laparotomy (LPT)
Number of subjects: 122
Study: 11840379

Group type: EXPERIMENTAL
Intervention: Chronic renal insufficiency
Number of subjects: 15
Study: 10341676

Group type: EXPERIMENTAL
Intervention: Test meal with 12% MUFA / 17% SFA
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Test meal with 17% MUFA / 12% SFA
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Test meal with 24% MUFA / 5% SFA
Number of subjects: 15
Study: 7499981

Group type: EXPERIMENTAL
Intervention: Glass ionomer cement sealer (Ketac‐Endo)
Number of subjects: 378
Study: 1958764

Group type: EXPERIMENTAL
Intervention: EEG sleep profiles during the first REM period of the recurrent episode
Number of subjects: 32

Group type: COMPARATOR
Intervention: Previous episode of depression
Number of subjects: 32
Study: 7044608

Group type: EXPERIMENTAL
Intervention: Medical management with early intensive therapy including nitrates and beta-blocking agents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Urgent surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elective surgery
Number of subjects: 0
Study: 31273863

Group type: COMPARATOR
Intervention: Strength Training on Stable Surfaces (ST)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Strength Training on Unstable Surfaces (UST)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 64
Study: 28961826

Group type: EXPERIMENTAL
Intervention: Whole brain radiotherapy (WBRT)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Whole brain radiotherapy (WBRT) among NSCLC patients
Number of subjects: 329